2023 Announcements

CLINUVEL
Posted by CLINUVEL
June 1, 2023

Strategic Update VI

CLINUVEL today announced its sixth Strategic Update.

Read More
CLINUVEL
Posted by CLINUVEL
May 31, 2023

CLINUVEL Bulletin Edition 01

The first in a new series providing updates on CLINUVEL's Brand Architecture,...

Read More
CLINUVEL
Posted by CLINUVEL
May 9, 2023

CLINUVEL escalates PRÉNUMBRA® to moderate/severe stroke patients

CLINUVEL announced the escalation of PRÉNUMBRA® Instant to moderate-to-severe and severe stroke...

Read More
CLINUVEL
Posted by CLINUVEL
May 1, 2023

Expansion of CLINUVEL’s global porphyria programs

CLINUVEL today released an update on the use its drug SCENESSE® (afamelanotide...

Read More
CLINUVEL
Posted by CLINUVEL
April 11, 2023

News Kommuniqué II

Melbourne, Australia, 12 January 2023 ASX: CUV XETRA-DAX: UR9 Level 1 ADR:...

Read More
CLINUVEL
Posted by CLINUVEL
April 7, 2023

News Communiqué I - Ms Cristina Ramos

Introducing CLINUVEL’s next Intriguing Personality (CUVIP), Ms Cristina Ramos.

Read More
CLINUVEL
Posted by CLINUVEL
April 5, 2023

News Communiqué II

Download the PDF Authorised for ASX release by the Board of Directors...

Read More
CLINUVEL
Posted by CLINUVEL
March 30, 2023

Investor Presentation - NYC Nasdaq Event

CLINUVEL hosted a Rendez-Vous evening event at the Nasdaq in New York...

Read More
CLINUVEL
Posted by CLINUVEL
March 20, 2023

First stroke patient treated with PRÉNUMBRA® Instant

CLINUVEL has started its second stroke trial (CUV803) with the first patient...

Read More
CLINUVEL
Posted by CLINUVEL
March 20, 2023

Technical note: Arterial Ischaemic Stroke (AIS)

This Technical Note provides further detail on the current standards of care...

Read More
CLINUVEL
Posted by CLINUVEL
March 17, 2023

DNA Repair data presented at American Academy of Dermatology Meeting

First results of afamelanotide in xeroderma pigmentosum C (XPC) presented to Photodermatology...

Read More
CLINUVEL
Posted by CLINUVEL
March 13, 2023

Statement on Silicon Valley Bank (SVB)

Melbourne, Australia, 13 March 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
Lachlan Hay
Posted by Lachlan Hay
March 10, 2023
CLINUVEL
Posted by CLINUVEL
March 10, 2023

News Communiqué I - Maestro Jaap van Zweden

Introducing CLINUVEL Intriguing Personality (CUVIP), Maestro Jaap van Zweden.

Read More
Lachlan Hay
Posted by Lachlan Hay
March 9, 2023

Commercial Update SCENESSE®

CLINUVEL today published its 2022 status report on the commercial distribution of...

Read More